In India, the pharmaceutical industry is the second-largest in terms of global GDP, with $13 trillion worth of goods and services exported.
There are about 50 pharma companies.
India’s pharmaceutical sector has been the focus of the recent controversies over the adulteration of india-made drugs by some companies, including india Pharmaceuticals Corporation Ltd (IPSCL), which was fined $8.5 billion last year.
IPSCL is India’s largest pharmaceutical company.
The government has taken steps to clamp down on the manufacturing of indian drugs, including increasing the price of indoequinone and restricting imports of indole-3-carbinol (ICC) for research and development.
India has about 40,000 drug companies, according to the World Bank.
But the pharmaceutical sector, as a whole, is growing at a slower pace than the rest of the economy.
It has expanded about 10% over the past five years, but the percentage of the population aged 20-64 has shrunk from 29% in 2007 to just 12% in 2016, according the International Monetary Fund.
The proportion of people under 65 has shrunk even more, from 17% in 2008 to just 11% in 2020, according data from the World Health Organization.
The growing problem of adulterating india drugs is due to a number of factors, including poor quality control, poor supply chain management and an unwillingness of pharmaceutical companies to use quality control measures, such as biosecurity checks.
The problem is also partly a result of the rise in the number of indoles produced, and more importantly, from India’s reliance on indole products.
In 2015, India imported about 2 million tonnes of indol-3 (ICCs) for medical use, according a survey by India’s National Drug Information Center (NDIC).
Indole-containing drugs were used in a whopping 78% of the Indian medicines sold in the US and Canada in 2015, according research by the Harvard School of Public Health and Harvard Medical School.
This equates to roughly one indole for every 100 people in India, or one per 1,400 people in the world, the NDIC report found.
India imports more than half of the world’s indoles, according an analysis by Bloomberg.
The rest is imported by the US, Canada, the UK, Germany and Japan.
India is also one of the few countries in the region where indole production is highly concentrated.
In India alone, the indole industry accounts for 15% of global production, according ICI, and India is home to about a quarter of the global indole exports.
Indole, a synthetic compound found in rice and other crops, has been used in many therapeutic uses since the 19th century.
In the 1980s, it was used in the treatment of rheumatoid arthritis and cancer, and in treating diabetes, according NDIC.
The growth in the pharmaceutical market has been a boon for the industry.
Indoequinones are drugs that mimic natural molecules, which are made from a substance called indole, which is made by the same group of molecules.
Indoles, the main indole ingredient in indole derivatives, have also been used for years in the manufacture of medical devices, pharmaceuticals, cosmetics, toothpastes and cosmetics.
In recent years, Indian companies have grown their supply chains and their products, including some of the most sought-after indole compounds.
Indolone is often referred to as a ‘miracle drug’ because it can work as a treatment for certain types of cancer and diabetes, and is able to block inflammation in the body.
Indonesia’s industry is now increasingly focused on indoles for cancer treatments, and it is one of only two countries where indoles are being used for cancer treatment.
It is the only one that has also started using indole to treat diabetes.
India also has a history of drug safety.
Last year, India’s Ministry of Health and Family Welfare announced a new strategy to make the country safer, including an overhaul of its existing drug regulations.
In recent years in India and elsewhere, the country has been grappling with the issue of corruption, which has been linked to drug manufacturing.
In April, the Supreme Court ruled that drug manufacturing should be banned in India.